Regarding mutations in the IRF2, ARID1A and HNF4α genes, our findings are in line with other reports which show low mutation rates in HBV-related HCC [41, 42], suggesting that these genes may not involve in HBV-related HCC tumorigenesis. The gene discussed is ARID1A; the disease is hepatocellular carcinoma.